Relation between treatment benefit and underlying risk in meta-analysis. Standard of "label invariance" should not be abandoned.

Documenti analoghi

• Relation between treatment benefit and underlying risk in meta-analysis
  di: Sharp, Stephen, et al.
  Pubblicazione: (1996)
• The relation between treatment benefit and underlying risk in meta-analysis.
  di: Sharp, S. J., et al.
  Pubblicazione: (1996)
• Should Diabetes Healthcare Abandon Its Gold Standard?
  di: Treviño, George
  Pubblicazione: (2007)
• N of 1 trials. Placebos should be abandoned.
  di: Treasure, W.
  Pubblicazione: (1996)
• Should benefit–risk assessment have its own drug “label”?
  di: Braithwaite, R Scott
  Pubblicazione: (2011)